← Leaderboards
John J Krolewski
University Of California Irvine
$4,496,359
Attributed
$4,678,784
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $365.7K · FY2006–23$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,678,784 · 7
By mechanism
R01$3,946,096 · 2
P30$367,838 · 4
UH2$364,850 · 1
Top collaborators
- Yvonne Margaret Saenger2 shared
Most similar at University Of California Irvine
Same institution · by research overlap
- Frank Louis Meyskens$19,843,890
- Sabee Y Molloi$10,648,883
- Kristen M Kelly$3,344,478
- Orhan Nalcioglu$5,072,098
- Christopher C. W. Hughes$22,189,863
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGenesMolecularMalignant Neoplasm Of ProstatePathway InteractionsResponseCancer TherapySignal PathwayResistanceNeoplastic CellInterferonsImageInnovationTumorTumorigenicMouse ModelGeneticCytokineDisease ProgressionAccountingEpigenetic ProcessRodent ModelSignal TransductionCell Line
Grant awards (26)
Genetics and Genomics$42,340
P30 · FY2023 · CA · contact PI
Genetics and Genomics$44,540
P30 · FY2022 · CA · contact PI
A prognostic mRNA immune signature for resected stage II-III melanoma$167,236
UH2 · FY2020 · CA
Genetics and Genomics$45,965
P30 · FY2020 · CA · contact PI
A prognostic mRNA immune signature for resected stage II-III melanoma$197,614
UH2 · FY2019 · CA
Genetics and Genomics$45,965
P30 · FY2019 · CA · contact PI
An Androgen-Regulated Cytokine Network Controls Prostate Apoptosis.$333,996
R01 · FY2016 · CA · contact PI
An Androgen-Regulated Cytokine Network Controls Prostate Apoptosis.$333,996
R01 · FY2015 · CA · contact PI
An androgen-regulated cytokine network controls prostate apoptosis$289,705
R01 · FY2014 · CA · contact PI
An androgen-regulated cytokine network controls prostate apoptosis$40,431
R01 · FY2013 · CA · contact PI
EXPERIMENTAL TISSUE SHARED RESOURCE$37,356
P30 · FY2013 · CA · contact PI
An androgen-regulated cytokine network controls prostate apoptosis$318,513
R01 · FY2012 · CA · contact PI
An androgen-regulated cytokine network controls prostate apoptosis$317,475
R01 · FY2011 · CA · contact PI
EXPERIMENTAL TISSUE SHARED RESOURCE$48,259
P30 · FY2011 · CA · contact PI
EXPERIMENTAL TISSUE SHARED RESOURCE$51,881
P30 · FY2010 · CA · contact PI
Signaling via proteolysis of the interferon receptor$258,343
R01 · FY2009 · CA · contact PI
EXPERIMENTAL TISSUE SHARED RESOURCE$51,532
P30 · FY2009 · CA · contact PI
Signaling via proteolysis of the interferon receptor$258,343
R01 · FY2008 · CA · contact PI
Signaling via proteolysis of the interferon receptor$258,343
R01 · FY2007 · CA · contact PI
Signaling via proteolysis of the interferon receptor$266,058
R01 · FY2006 · CA · contact PI
TYK2 AND IFNAR1 IN INTERFERON ALPHA SIGNALING$267,750
R01 · FY2004 · CA
TYK2 AND IFNAR1 IN INTERFERON ALPHA SIGNALING$261,864
R01 · FY2003 · CA
TYK2 AND IFNAR1 IN INTERFERON ALPHA SIGNALING$254,432
R01 · FY2002 · CA
CORE--TRANSLATIONAL PATHOLOGY FACILITY$0
P30 · FY2002 · CA
TYK2 AND IFNAR1 IN INTERFERON ALPHA SIGNALING$247,021
R01 · FY2001 · CA
TYK2 AND IFNAR1 IN INTERFERON ALPHA SIGNALING$239,826
R01 · FY2000 · CA